|
AREDS2 DNA Detail
|
|
|
| Records Return:
(53)
|
|
|
|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_1195 | ED148252 | General Research Use | No | Female | White | 80 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1230 | ED148799 | General Research Use | No | Male | White | 75 | 10 - Central GA | 10 - Central GA |
| AR2_2125 | ED149845 | General Research Use | No | Female | White | 83 | 10 - Central GA | 10 - Central GA |
| AR2_0105 | ED148642 | General Research Use | No | Male | White | 83 | 10 - Central GA | 10 - Central GA |
| AR2_0824 | ED148333 | General Research Use | No | Female | White | 81 | 10 - Central GA | 10 - Central GA |
| AR2_2273 | ED149904 | General Research Use | No | Female | White | 83 | 10 - Central GA | 10 - Central GA |
| AR2_3086 | ED148081 | General Research Use | No | Female | White | 80 | 10 - Central GA | 10 - Central GA |
| AR2_2461 | ED149780 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_2799 | ED148768 | General Research Use | No | Female | White | 70 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2999 | ED148535 | General Research Use | No | Male | White | 81 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_3395 | ED148551 | General Research Use | No | Female | White | 76 | 10 - Central GA | 10 - Central GA |
| AR2_3441 | ED148921 | General Research Use | No | Male | White | 63 | 10 - Central GA | 10 - Central GA |
| AR2_3962 | ED148641 | General Research Use | No | Male | White | 77 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1048 | ED148644 | General Research Use | No | Male | White | 81 | 10 - Central GA | 10 - Central GA |
| AR2_1287 | ED149861 | General Research Use | No | Male | White | 60 | 10 - Central GA | 10 - Central GA |
| AR2_1681 | ED148292 | General Research Use | No | Male | White | 82 | 10 - Central GA | 10 - Central GA |
| AR2_2042 | ED149849 | General Research Use | No | Female | White | 78 | 10 - Central GA | 10 - Central GA |
| AR2_2950 | ED148983 | General Research Use | No | Female | White | 84 | 10 - Central GA | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2987 | ED149556 | General Research Use | No | Male | White | 79 | 10 - Central GA | 10 - Central GA |
| AR2_3003 | ED148277 | General Research Use | No | Female | White | 80 | 10 - Central GA | 10 - Central GA |
|
|
|
|